Also categorized in BoardMoves:
Amazon's Board Diversity Push Could Destroy Traditional Retail
x hide permanently

Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors


Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of Konstantin Konstantinov, Ph.D., a life sciences and bioprocessing industry expert. Dr. Konstantinov brings to the director role nearly 30 years of relevant experience, including his current position as Chief Technology Officer at Codiak BioSciences...

Mentions: Nasdaq technology Repligen Corporation